Finished Drugs
Nucleosides series
New inhibitors and intermediates
Cardiovascular&Antidiabetic API and intermediates
Anti-tumor and cancer API and intermediates
Antibiotics APIs and intermediates
Antipsychotic API and intermediates
Anti-virus API and intermediates
Dermopathic API and intermediates
Histamine API and intermediates
Gastrointestinal stromal API and intermediates
Vitamin Amino acids and nutraceuticals series
Steroid hormones and other intermediates
PVP Homopolymers and special chemicals
Pharmaceutical Excipients
XINXIANG BEST PHARMACEUTICAL CO.,LTD. Sales email：sales@bstpharm.com OEM email：research@bstpharm.com Purchase＆import email：purchase@bstpharm.com Tel：0086-373-6378323 Fax：0086-373-3809550 Website：www.bstpharm.com www.xxbestpharm.com Address：Hualan Road 509,Xinxiang City,Henan.China 45300
| No | Name | Standard | CAS NO | Remarks |
|---|---|---|---|---|
| R001 | 7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one | 99.0% | 160129-45-3 | Tolvaptan intermediates |
| R002 | Pranlukast | 99.0% | 103177-37-3 | Anti-asthmatics |
| R003 | 4-(4-PHENYLBUTOXY)BENZOIC ACID | 99.0% | 30131-16-9 | Pranlukast inter |
| R004 | 8-AMINO-4-OXO-2-(TETRAZOL-5-YL)-4H-1-BENZO PYRAN HYDROCHOLRIDE | 99.0% | 110683-23-3 | Pranlukast inter |
| R005 | N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride | 99.0% | 482577-59-3 | Satans inters |
| R006 | DOTA | 99.0% | 60239-18-1 | Contrast agent inter |
| R007 | Cyclen | 99.0% | 294-90-6 | Contrast agent inter |
| R008 | 1,4,8,11-Tetraazacyclotetradecane | 99.0% | 295-37-4 | Plerixafor inter |
| R009 | 2-Chloronicotinic Acid | 99.0% | 2942-59-8 | Peptide inters |
| R010 | 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid | 99.0% | 11102811-72-0 | MOXIFLOXACIN INTERMEDIATES |
| R011 | 4-Chloro-2-nitrobenzoic acid | 99.0% | 6280-88-2 | Satans inter. |
| R012 | 2-amino-3-（1,2-dihydro-2-oxo-4-quinolyl)propionic acid dihydrochloride dehydrate | 99.0% | 5162-90-3 | Rebamipide intermediate |
| R013 | Silodosin | 99.0% | 160970-54-7 | treatment benign prostatic hyperplasia |
| R014 | 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R -2,3-dihydroxybutanedioate | 99.0% | 239463-85-5 | Silodosin inter |
| RO15 | 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate | 99.0% | 160969-03-9 | Silodosin inter |
| R016 | 3-[[(1,1-DiMethylethyl)diMethylsilyl]oxy]-1-propanol, 4nitrobenzenesulfonate | 99.0% | 220299-14-9 | Silodosin inter |
| R017 | 1-Acetyl-5-(2-aminopropyl)-2,3-dihydroindole-7-carbonitrile | 99.0% | 175837-01-1 | Silodosin inter |
| R018 | N-(3-aminophenyl)acrylamide | 99.0% | 16230-24-3 | inter |
| R019 | 4-(2-Methoxyethoxy)aniline | 99.0% | 33311-29-4 | inter |
| R020 | Stanolone | 99.0% | 521-18-6 | API |
| R021 | 4-Nitrobenzyl bromide | 99.0% | 100-11-8 | Intermediate |
| R022 | N-(3-aminophenyl)acrylamide | 99.0% | 16230-24-3 | Intermediate |
| R023 | R-(-)-O-Chloromandelic acid | 99.0% | 52950-18-2 | Intermediate |
| R024 | (S)-(+)-Tartrate of methyl –α-amino(2-chlorophenyl) acetate | 99.0% | 141109-14-0 | Intermediate |
| R025 | 2-(2-thienyl)ethyl toluene-p-sulphonate | 99.0% | 40412-06-4 | Intermediate |
| R026 | DECABORANE | 99.0% | 17702-41-9 | Intermediate |
| R027 | o-Carborane | 98.0% | 16872-09-6 | Intermediate |
| R028 | M-CARBORANE | 99.0% | 16986-24-6 | Intermediate |
| R029 | Acridine | 99.0% | 260-94-6 | Intermediate |
| R030 | 9(10H)-ACRIDONE | 99.0% | 578-95-0 | Intermediate |